Plethysmograph Market Outlook:
Plethysmograph Market size was over USD 117.96 million in 2025 and is poised to exceed USD 197.71 million by 2035, witnessing over 5.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of plethysmograph is estimated at USD 123.59 million.
The growth of the market can be attributed to the increasing prevalence of chronic respiratory diseases, such as asthma and COPD, as well as the growing demand for accurate diagnosis of respiratory diseases. As of 2019, chronic respiratory diseases accounted for 534,242 deaths in North America, with 50% of deaths occurring in men and 50% in women. The mortality rate among men (42.2 deaths per 100,000) was higher than the mortality rate among women (31.0 deaths per 100,000). Plethysmographs are used to measure the volume of air in the lungs, as well as the amount of oxygen that is inhaled and exhaled. As the prevalence of respiratory diseases increases, the need for more accurate and reliable measurement of air volume and oxygen levels also increases, driving up the market growth.
In addition to these, factors that are believed to fuel the market growth of plethysmographs include growing awareness about health and well-being, increasing prevalence of lifestyle diseases, rising demand for non-invasive and painless diagnostic procedures, Moreover, technological advances in medical devices enable the development of next-generation plethysmographs, which is projected to drive market growth in coming years. For instance, COSMED's Q-Box is an advanced body box designed to accurately measure thoracic gas volume, including static lung volume (TLC, RV, and ITGV) and airway resistance and conductance (RAW and GAW) using complete body plethysmography.
Key Plethysmograph Market Insights Summary:
Regional Insights:
- By 2035, North America is expected to command nearly 35% share of the Plethysmograph Market over 2026–2035, propelled by growing awareness of preventive healthcare.
- The Asia Pacific region is set to hold around 27% share by 2035, supported by the rising demand for ambulatory monitoring systems.
Segment Insights:
- By 2035, the hospital segment in the Plethysmograph Market is anticipated to attain about 45% share during 2026–2035, stimulated by the rising number of hospital-based procedures.
- The limb plethysmograph segment is projected to capture nearly 38% share by 2035, strengthened by the increasing prevalence of chronic illnesses such as hypertension and diabetes.
Key Growth Trends:
- Rising Popularity of Remote Monitoring Among Patients
- Continuous Improvement in Healthcare Technology
Major Challenges:
- High cost of plethysmographs and their associated accessories
- Unawareness regarding the use of plethysmographs in remote areas
Key Players: SCIREQ, Vyaire Medical, ACI Medical LLC, BioTekna Srl, D. E. Hokanson Inc., Geratherm Medical AG, medical equipment Europe GmbH, Medizinische Messtechnik GmbH, MGC Diagnostics Corp., Piston Ltd.
Global Plethysmograph Market Forecast and Regional Outlook:
Market Size & Growth Projections:
- 2025 Market Size: USD 117.96 million
- 2026 Market Size: USD 123.59 million
- Projected Market Size: USD 197.71 million by 2035
- Growth Forecasts: 5.3%
Key Regional Dynamics:
- Largest Region: Europe (Majority Share by 2035)
- Fastest Growing Region: Asia Pacific
- Dominating Countries: United States, Germany, United Kingdom, China, Japan
- Emerging Countries: India, South Korea, Brazil, Mexico, Australia
Last updated on : 24 November, 2025
Plethysmograph Market - Growth Drivers and Challenges
Growth Drivers
- Rising Popularity of Remote Monitoring Among Patients - According to a survey conducted in 2020, 22 million U.S. patients used remote patient monitoring tools and services. It is expected that 29 million U.S. patients will have access to remote patient monitoring devices and tools by 2024. Remote monitoring allows patients to track their health from the comfort of their homes, using devices such as plethysmographs, which measure blood oxygen levels and respiration rates. This eliminates the need for frequent hospital visits, increasing convenience for the patient and reducing healthcare costs for the provider.
- Continuous Improvement in Healthcare Technology - For instance, wearable photoplethysmography sensors are the latest technological advancements in plethysmographs. This technology has enabled the development of more accurate and reliable devices for measuring human vital signs, such as heart rate and respiration. These devices can be used for medical diagnostics, research, and monitoring of health and fitness.
- Increasing Number of Geriatrics Worldwide - As people age, they are more prone to suffer from respiratory illnesses such as asthma, COPD, and other chronic conditions. Plethysmographs are used to measure the volume of air in and out of the lungs, which helps diagnose these conditions. For instance, In accordance with the World Ageing Report 2019, it is expected that the number of people aged 65 and over will reach 83.813 million by 2050, up from 53.340 million in 2019. With the growing global geriatric population, the demand for plethysmographs is expected to rise.
- Rise in the Number of Tobacco Smoking - According to the World Health Organization, tobacco is responsible for the death of more than 8 million individuals annually. Approximately 22.3% of the world's population smoked in 2020, along with 36.7% of men and 7.8% of women. As more people take up smoking, there is an increasing need for accurate and reliable medical diagnostic devices to monitor respiratory health. Plethysmographs measure changes in the volume of a body part, usually the lungs, and are used to detect abnormalities in lung function.
- Rising Prevalence of Chronic Obstructive Pulmonary Disease (COPD) - COPD is a serious lung condition characterized by difficulty breathing. As COPD becomes more common, diagnostics and treatments are needed. According to statistics released by the World Health Organization, COPD ranks third in mortality worldwide, causing 3.23 million deaths in the year 2019. This has contributed to an increased demand for plethysmographs, which are devices used to diagnose and monitor COPD.
Challenges
- High cost of plethysmographs and their associated accessories- The high cost of plethysmographs and their associated accessories is due to the expensive components used in the plethysmograph system, such as pressure transducers and amplifiers, which increase the overall cost of the system. Additionally, the cost of calibration and maintenance of the plethysmograph system can also be expensive and is a major factor hindering market expansion.
- Unawareness regarding the use of plethysmographs in remote areas
- Lack of trained professionals to operate the equipment
Plethysmograph Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
5.3% |
|
Base Year Market Size (2025) |
USD 117.96 million |
|
Forecast Year Market Size (2035) |
USD 197.71 million |
|
Regional Scope |
|
Plethysmograph Market Segmentation:
End-user Segment Analysis
The global plethysmograph market is segmented and analyzed for demand and supply by end use into hospitals, clinics, and others. Out of these, the hospital segment is estimated to gain the largest market share of about 45% in the year 2035. The growth of the segment can be attributed to the rising number of hospital-based procedures, the increasing prevalence of chronic diseases, and technological advancements in plethysmograph devices are some of the factors driving the growth of the hospital segment. Additionally, government initiatives to promote the use of medical devices in healthcare facilities is further augmenting the market growth. For instance, the Government of India has initiated a program known as the National Health Mission, which is designed to provide free diagnostic services in hospitals with the help of noninvasive and low-cost tools to improve patients’ clinical outcomes.
Type Segment Analysis
The global market is segmented and analyzed for demand and supply by type into body plethysmograph, limb plethysmograph, and others. Out of these, the limb plethysmograph segment is estimated to gain a significant market share of about 38% in the year 2035. The growth of the segment can be attributed to the increasing prevalence of chronic illnesses such as hypertension and diabetes, which require frequent monitoring of limb volume. The limb plethysmograph is a non-invasive device that can measure the amount of blood flow in the limbs, which is important for monitoring hypertension and diabetes. Additionally, advancements in technology have made plethysmographs more accurate and user-friendly, and market players are launching products with these features, which is boosting the demand for plethysmographs.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Application |
|
|
By End Use |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Plethysmograph Market - Regional Analysis
North American Market Insights
North America industry is likely to account for largest revenue share of 35% by 2035. The growth of the market can be attributed majorly to the increasing awareness of the importance of preventive healthcare, and rising incidences of lung diseases such as asthma. According to the Asthma and Allergy Foundation of America, in the U.S., nearly 26 million people suffer from asthma and nearly 21 million Americans ages 18 and older suffer from asthma. In 2020, approximately 52.9% of children under the age of 5 suffering from asthma had an asthma attack. Asthma is a chronic lung disease that causes breathing difficulties and wheezing. The use of a plethysmograph allows doctors to measure the amount of air that a person can breathe in and out, which is helpful in diagnosing and monitoring asthma. In addition, advancements in connected healthcare technologies and the growing adoption of digital health solutions along with increasing demand for remote patient monitoring among regional populations are also driving the growth of the market in North America.
APAC Market Insights
The Asia Pacific plethysmograph market is estimated to be the second largest, registering a share of about ~27% by the end of 2035. The growth of the market can be attributed majorly to the rising demand for ambulatory monitoring systems and the increasing prevalence of obesity as a result of sedentary lifestyles among the regional population. Obesity can contribute to a number of health issues such as cardiovascular diseases and respiratory problems, which in turn increases the demand for medical care and monitoring. Plethysmographs are used to monitor pulmonary function and are therefore in high demand in the Asia Pacific region attributable to the rising number of obese individuals. Additionally, increasing awareness about the advantages of plethysmograph testing and the availability of cost-effective plethysmograph systems in the region are also expected to drive market growth in the region.
Europe Market Insights
Further, the plethysmograph market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The growth of the market can be attributed majorly to the rising awareness about the benefits of the plethysmograph, the growing demand for technologically advanced medical devices, and the increasing demand for non-invasive diagnostic procedures. The growing number of people addicted to liquor and Smoking is also contributing to product demand in the region. Alcohol and smoking damage the lungs, making them more vulnerable to infection and diseases. This increases the need for accurate and reliable diagnostic tools, such as plethysmographs, to detect and diagnose respiratory problems.
Plethysmograph Market Players:
- SCIREQ
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Vyaire Medical
- ACI Medical LLC
- BioTekna Srl
- D. E. Hokanson Inc.
- Geratherm Medical AG
- medical equipment Europe GmbH,
- Medizinische Messtechnik GmbH
- MGC Diagnostics Corp.
- Piston Ltd.
Recent Developments
- An innovative portable plethysmograph, the Pneupac Solo PV2, was introduced by Vyaire Medical. The device is designed to measure the volume of air that is inhaled and exhaled, making it easier for doctors to diagnose and monitor asthma and other respiratory conditions. It is also designed to be lightweight and portable, making it easy to use in the home or on the go.
- A new SCIREQ product, the vivoFlow - WBP (Whole Body Plethysmograph Chamber), was unveiled at the Experimental Biology Meeting. As well as being fully compatible with current systems, the vivoFlow has a number of design features that both improve the quality of data and make it easier to use.
- Report ID: 4878
- Published Date: Nov 24, 2025
- Report Format: PDF, PPT
- Explore a preview of key market trends and insights
- Review sample data tables and segment breakdowns
- Experience the quality of our visual data representations
- Evaluate our report structure and research methodology
- Get a glimpse of competitive landscape analysis
- Understand how regional forecasts are presented
- Assess the depth of company profiling and benchmarking
- Preview how actionable insights can support your strategy
Explore real data and analysis
Frequently Asked Questions (FAQ)
Plethysmograph Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
See how top U.S. companies are managing market uncertainty — get your free sample with trends, challenges, macroeconomic factors, charts, forecasts, and more.
Copyright @ 2025 Research Nester. All Rights Reserved.
Afghanistan (+93)
Åland Islands (+358)
Albania (+355)
Algeria (+213)
American Samoa (+1684)
Andorra (+376)
Angola (+244)
Anguilla (+1264)
Antarctica (+672)
Antigua and Barbuda (+1268)
Argentina (+54)
Armenia (+374)
Aruba (+297)
Australia (+61)
Austria (+43)
Azerbaijan (+994)
Bahamas (+1242)
Bahrain (+973)
Bangladesh (+880)
Barbados (+1246)
Belarus (+375)
Belgium (+32)
Belize (+501)
Benin (+229)
Bermuda (+1441)
Bhutan (+975)
Bolivia (+591)
Bosnia and Herzegovina (+387)
Botswana (+267)
Bouvet Island (+)
Brazil (+55)
British Indian Ocean Territory (+246)
British Virgin Islands (+1284)
Brunei (+673)
Bulgaria (+359)
Burkina Faso (+226)
Burundi (+257)
Cambodia (+855)
Cameroon (+237)
Canada (+1)
Cape Verde (+238)
Cayman Islands (+1345)
Central African Republic (+236)
Chad (+235)
Chile (+56)
China (+86)
Christmas Island (+61)
Cocos (Keeling) Islands (+61)
Colombia (+57)
Comoros (+269)
Cook Islands (+682)
Costa Rica (+506)
Croatia (+385)
Cuba (+53)
Curaçao (+599)
Cyprus (+357)
Czechia (+420)
Democratic Republic of the Congo (+243)
Denmark (+45)
Djibouti (+253)
Dominica (+1767)
Dominican Republic (+1809)
Timor-Leste (+670)
Ecuador (+593)
Egypt (+20)
El Salvador (+503)
Equatorial Guinea (+240)
Eritrea (+291)
Estonia (+372)
Ethiopia (+251)
Falkland Islands (+500)
Faroe Islands (+298)
Fiji (+679)
Finland (+358)
France (+33)
Gabon (+241)
Gambia (+220)
Georgia (+995)
Germany (+49)
Ghana (+233)
Gibraltar (+350)
Greece (+30)
Greenland (+299)
Grenada (+1473)
Guadeloupe (+590)
Guam (+1671)
Guatemala (+502)
Guinea (+224)
Guinea-Bissau (+245)
Guyana (+592)
Haiti (+509)
Honduras (+504)
Hong Kong (+852)
Hungary (+36)
Iceland (+354)
India (+91)
Indonesia (+62)
Iran (+98)
Iraq (+964)
Ireland (+353)
Isle of Man (+44)
Israel (+972)
Italy (+39)
Jamaica (+1876)
Japan (+81)
Jersey (+44)
Jordan (+962)
Kazakhstan (+7)
Kenya (+254)
Kiribati (+686)
Kuwait (+965)
Kyrgyzstan (+996)
Laos (+856)
Latvia (+371)
Lebanon (+961)
Lesotho (+266)
Liberia (+231)
Libya (+218)
Liechtenstein (+423)
Lithuania (+370)
Luxembourg (+352)
Macao (+853)
Madagascar (+261)
Malawi (+265)
Malaysia (+60)
Maldives (+960)
Mali (+223)
Malta (+356)
Marshall Islands (+692)
Mauritania (+222)
Mauritius (+230)
Mayotte (+262)
Mexico (+52)
Micronesia (+691)
Moldova (+373)
Monaco (+377)
Mongolia (+976)
Montenegro (+382)
Montserrat (+1664)
Morocco (+212)
Mozambique (+258)
Myanmar (+95)
Namibia (+264)
Nauru (+674)
Nepal (+977)
Netherlands (+31)
New Caledonia (+687)
New Zealand (+64)
Nicaragua (+505)
Niger (+227)
Nigeria (+234)
Niue (+683)
Norfolk Island (+672)
North Korea (+850)
Northern Mariana Islands (+1670)
Norway (+47)
Oman (+968)
Pakistan (+92)
Palau (+680)
Palestine (+970)
Panama (+507)
Papua New Guinea (+675)
Paraguay (+595)
Peru (+51)
Philippines (+63)
Poland (+48)
Portugal (+351)
Puerto Rico (+1787)
Qatar (+974)
Romania (+40)
Russia (+7)
Rwanda (+250)
Saint Barthélemy (+590)
Saint Helena, Ascension and Tristan da Cunha (+290)
Saint Kitts and Nevis (+1869)
Saint Lucia (+1758)
Saint Martin (French part) (+590)
Saint Pierre and Miquelon (+508)
Saint Vincent and the Grenadines (+1784)
Samoa (+685)
San Marino (+378)
Sao Tome and Principe (+239)
Saudi Arabia (+966)
Senegal (+221)
Serbia (+381)
Seychelles (+248)
Sierra Leone (+232)
Singapore (+65)
Sint Maarten (Dutch part) (+1721)
Slovakia (+421)
Slovenia (+386)
Solomon Islands (+677)
Somalia (+252)
South Africa (+27)
South Georgia and the South Sandwich Islands (+0)
South Korea (+82)
South Sudan (+211)
Spain (+34)
Sri Lanka (+94)
Sudan (+249)
Suriname (+597)
Svalbard and Jan Mayen (+47)
Eswatini (+268)
Sweden (+46)
Switzerland (+41)
Syria (+963)
Taiwan (+886)
Tajikistan (+992)
Tanzania (+255)
Thailand (+66)
Togo (+228)
Tokelau (+690)
Tonga (+676)
Trinidad and Tobago (+1868)
Tunisia (+216)
Turkey (+90)
Turkmenistan (+993)
Turks and Caicos Islands (+1649)
Tuvalu (+688)
Uganda (+256)
Ukraine (+380)
United Arab Emirates (+971)
United Kingdom (+44)
Uruguay (+598)
Uzbekistan (+998)
Vanuatu (+678)
Vatican City (+39)
Venezuela (Bolivarian Republic of) (+58)
Vietnam (+84)
Wallis and Futuna (+681)
Western Sahara (+212)
Yemen (+967)
Zambia (+260)
Zimbabwe (+263)